Notably absent from AGN pipeline discussion on today’s CC: bimatoprost for androgenetic alopecia (male/female pattern baldness). This was once considered AGN’s hottest pipeline program, ahead of even DARPin.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”